Bravias Capital Group, LLC Merck & Co., Inc. Transaction History
Bravias Capital Group, LLC
- $150 Billion
- Q3 2025
A detailed history of Bravias Capital Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bravias Capital Group, LLC holds 4,638 shares of MRK stock, worth $430,684. This represents 0.26% of its overall portfolio holdings.
Number of Shares
4,638
Previous 3,255
42.49%
Holding current value
$430,684
Previous $258 Million
51.08%
% of portfolio
0.26%
Previous 0.19%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,875Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...